GALAD评分
基于血清肿瘤标志物诊断HCC
Diagnoses HCC based on serum biomarkers in patients with chronic liver disease
指标 数值/描述
性别(gender)
年龄(age)
AFP
AFP-L3
DCP(PIVKA-II)
公式：-10.08 + 0.09×age+ 1.67×sex + 2.34×log10afp + 0.04×afpl3 + 1.33×log10dcp

        

Reference:
Philip J Johnson, Sarah J Pirrie, Trevor F Cox, etc. The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers.Cancer Epidemiol Biomarkers Prev . 2014 Jan;23(1):144-53. doi: 10.1158/1055-9965.EPI-13-0870.